We have received text from H.R. 4317: Pharmacy Benefit Manager Reform Act of 2025. This bill was received on 2025-07-10, and currently has 20 cosponsors.
Here is a short summary of the bill:
The "Pharmacy Benefit Manager Reform Act of 2025" seeks to enhance access and choices for Medicare beneficiaries by allowing all willing pharmacies to take part in prescription drug plans. The legislation sets forth a series of regulations and requirements for pharmacy benefit managers (PBMs), which are entities that manage prescription drug benefits on behalf of health insurers.
Key Provisions of the Bill
- Participation of Pharmacies: The bill ensures that any pharmacy that wishes to participate in prescription drug plans can do so, aimed at increasing accessibility for beneficiaries.
- Transparency and Reporting Requirements: PBMs are required to disclose their compensation structures and report on the relationship between themselves and health plans. This is designed to foster transparency within the healthcare system.
- Drug Pricing Oversight: PBMs must report detailed information on drug costs, including wholesale acquisition costs, average wholesale prices, the number of prescription claims processed, overall spending, and any rebates provided. This initiative aims to shed light on drug pricing and expenses associated with group health plans.
- Standardized Reporting: The bill mandates the Secretary to develop standard reporting requirements and formats for group health plans and PBMs, targeting drug manufacturers, to help prevent anti-competitive practices in the market.
- Dissemination of Information: Health plans will be required to provide relevant information to their participants, ensuring that beneficiaries are well-informed about their prescription drug benefits.
- Compliance and Penalties: The legislation introduces enforcement mechanisms and sets penalties for non-compliance with the established regulations, intending to hold PBMs accountable for adhering to contract terms.
The overall goal of the Pharmacy Benefit Manager Reform Act of 2025 is to create a more transparent, competitive, and accessible prescription drug market for Medicare beneficiaries, ultimately aiming to promote better cost management within healthcare.
Relevant Companies
- None found
Representative Earl L. "Buddy" Carter Bill Proposals
Here are some bills which have recently been proposed by Representative Earl L. "Buddy" Carter:
- H.R.4488: To provide for the issuance of a Veterans Health Care Stamp.
- H.R.4442: CHARGE Investments Act
- H.R.4425: To amend the Public Health Service Act to increase the number of permanent faculty in palliative care at accredited allopathic and osteopathic medical schools, nursing schools and other programs, including social work, physician assistant, and chaplaincy education programs, to promote education and research in palliative care and hospice, and to support the development of faculty careers in academic palliative and hospice care.
- H.R.4317: PBM Reform Act of 2025
- H.R.4218: CLEAR Act
- H.R.3950: To defend women's rights and protect freedom of conscience by using clear and accurate language and policies recognizing that women are biologically female and men are biologically male, and for other purposes.
You can track bills proposed by Representative Earl L. "Buddy" Carter on Quiver Quantitative's politician page for Carter.
Representative Earl L. "Buddy" Carter Net Worth
Quiver Quantitative estimates that Representative Earl L. "Buddy" Carter is worth $27.8M, as of July 29th, 2025. This is the 36th highest net worth in Congress, per our live estimates.
Carter has approximately $3.4M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Earl L. "Buddy" Carter's net worth on Quiver Quantitative's politician page for Carter.
Representative Earl L. "Buddy" Carter Stock Trading
We have data on up to $23.1M of trades from Representative Earl L. "Buddy" Carter, which we parsed from STOCK Act filings. Some of the largest trades include:
- A July 19th, 2024 sale of up to $250K of $ABCB. The stock has risen 13.27% since then.
You can track Representative Earl L. "Buddy" Carter's stock trading on Quiver Quantitative's politician page for Carter.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
